Role of Kinshuktwagadi ghan vati and Darvyadi ghanavati in Prediabetes.

A Randomized controlled Parallel two arm study to evaluate the effect of Kinshuktwagadi ghan vati and Darvyadi ghanavati in the management of Prameha WSR to Prediabetes .

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020978

Enrollment

140

Registered

2019-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Trial group Kinshukatwagadi ghan Vati: S.N. Drug Latin name Quantity Parts used 1Kinshuk/Palasha Butea Monosperma Lam 1 part Twak 2Nisha Curcuma longa Linn 1 part Kanda 3Dhatri Embili

Eligibility

Inclusion criteria

Inclusion criteria: Patients between age 18-60 yrs; irrespective of sex and socioeconomic status will be selected for the study. 2. Newly diagnosed cases of hyperglycaemia with lakshanas of Prameha like Prabhut mootrata, Trishna, Kshudhadhikya, Dourbalya, Dantadinammaladhyatvam, Atinidra with Madhumeha Assessment Tool (As mentioned in case paper) Score more than 10 and patients those having Blood Sugar level fasting 100 to 125, Postprandial Blood sugar level more than 140 and less than 200 and HbA1C 5.7 to 6.4 % will be selected for the study.

Exclusion criteria

Exclusion criteria: 1. Type 2 Diabetes Patients, Juvenile Diabetes, Pregnancy induced Diabetes Mellitus patients will be excluded from study. 2. Diabetes produced due to other illness like acromegaly, cushing Syndrome, pancreatic disorders will be excluded from study. 3. Patients Suffering from Diabetic Complications like Neuropathy, Retinopathy, Nephropathy, keto acidosis, Gangrene will be excluded from study. 4. Immune deficiency patient, chronic major illness will be also excluded from study.

Design outcomes

Primary

Measure	Time frame
Blood Sugar Level HbA1C Prabhootamootrata (Polyurea) Trishna (Polydipsia) Kshudhadhikya (Polyphagia) Dourbalya (General Weakness) DantadinamMaladyatvam(Increased coating /secretions in eyes,ears,nose,mouth,teeth tongue) Atinidra (Hypersomnia) Timepoint: 90 days	—

Secondary

Measure	Time frame
Prabhootamootrata (Polyurea) Trishna (Polydipsia) Kshudhadhikya (Polyphagia) Dourbalya (General Weakness) DantadinamMaladyatvam(Increased coating /secretions in eyes,ears,nose,mouth,teeth tongue) Atinidra (Hypersomnia) Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDR SANJAY SAKHARAM PATIL

Institute of Ayurveda Parul University Vadodara

dr_kbroy@yahoo.com9825912141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026